123 related articles for article (PubMed ID: 231597)
1. Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus.
Spittle MF; Bush H; James SE; Hellmann K
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1649-51. PubMed ID: 231597
[No Abstract] [Full Text] [Related]
2. [Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
Hassenstein E; Rhomberg W
Med Klin; 1977 Feb; 72(5):171-5. PubMed ID: 403395
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung.
Corder MP; Tewfik HH; Clamon GH; Platz CE; Leimert JT; Herbst KD; Byfield JE
Cancer; 1984 May; 53(9):1852-6. PubMed ID: 6322961
[TBL] [Abstract][Full Text] [Related]
4. Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
Hellmann K; Ryall RD; Macdonald E; Newton KA; James SE; Jones S
Cancer; 1978 Jan; 41(1):100-7. PubMed ID: 414829
[TBL] [Abstract][Full Text] [Related]
5. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
[No Abstract] [Full Text] [Related]
6. Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.
Newman CE; Cox R; Ford CH; Johnson JR; Jones DR; Wheaton M
Br J Cancer; 1985 May; 51(5):731-2. PubMed ID: 3888243
[No Abstract] [Full Text] [Related]
7. Small-cell carcinoma of the bronchus--real progress is hard to come by.
Lancet; 1980 Jan; 1(8159):77-8. PubMed ID: 6101423
[No Abstract] [Full Text] [Related]
8. Letter: Treatment of inoperable carcinoma of bronchus.
Laing AH; Berry RJ; Newman CR; Peto J
Lancet; 1976 Feb; 1(7956):428-9. PubMed ID: 55697
[No Abstract] [Full Text] [Related]
9. Phase I trial of cisplatin and razoxane (ICRF-159) (NSC #119875) in advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Pilot Study.
Bonomi P; Yordan E; Blessing JA
Am J Clin Oncol; 1988 Feb; 11(1):1-2. PubMed ID: 3277372
[TBL] [Abstract][Full Text] [Related]
10. ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma. A double-blind study.
Belloni C; Mangioni C; Bortolozzi G; Carinelli S; D'Incalci M; Maggioni A; Morasca L
Oncology; 1983; 40(3):181-5. PubMed ID: 6341912
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial.
Cox JD; Petrovich Z; Paig C; Stanley K
Cancer; 1978 Sep; 42(3):1135-40. PubMed ID: 212171
[No Abstract] [Full Text] [Related]
12. Archibald Reid Memorial Thesis, 1976. Treatment of the lymphomata and oat cell carcinoma of the bronchus by whole body radiotherapy.
Monaghan M
Radiography; 1977 Feb; 43(506):25-43. PubMed ID: 190635
[No Abstract] [Full Text] [Related]
13. [Clinical experiences with radiotherapy and ICRF 159 in sarcomas].
Rhomberg W; Mesche E; Gefeller D; Hassenstein E
Strahlentherapie Sonderb; 1978; 75():110-4. PubMed ID: 400195
[No Abstract] [Full Text] [Related]
14. A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma.
Corder MP; McFadden DB; Bell SJ
Cancer; 1984 Oct; 54(8):1496-8. PubMed ID: 6383594
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Conroy JF; Blessing JA; Kessinger A; Homesley HD
Cancer Treat Rep; 1984 Feb; 68(2):439-40. PubMed ID: 6697335
[No Abstract] [Full Text] [Related]
16. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
Marciniak TA; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(4):761-3. PubMed ID: 1100228
[No Abstract] [Full Text] [Related]
17. A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Gilbert JM; Cassell PC; Ellis H; Wastell C; Hellmann K; Evans MG; Stoodley BJ
Recent Results Cancer Res; 1981; 79():48-58. PubMed ID: 7029684
[TBL] [Abstract][Full Text] [Related]
18. Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma.
Ryall RD; Bates T; Newton KA; Hellmann K
Cancer; 1979 Sep; 44(3):891-5. PubMed ID: 113077
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
Wheeler RH; Bricker LJ; Natale RB; Baker SR
Cancer Treat Rep; 1984 Feb; 68(2):427-8. PubMed ID: 6421483
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
DeSimone PA; Greco FA; Omura GA; Bartolucci A
Am J Clin Oncol; 1986 Jun; 9(3):185-6. PubMed ID: 3728369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
